Barclays sees four key catalysts ahead for this 'overlooked' investment opportunity

  • 📰 CNBC
  • ⏱ Reading Time:
  • 21 sec. here
  • 18 min. at publisher
  • 📊 Quality Score:
  • News: 68%
  • Publisher: 72%

In Vitro Fertilization ニュース

Health Insurance,Biotech And Pharmaceuticals,Stock Markets

Barclays sees an improvement in the investment narrative for fertility stocks. These are names on its buy list.

There are a number of catalysts ahead for fertility stocks and many investors may be missing out, according to Barclays. The bank recently analyzed stocks tied to the theme and spoke with investors about it. "Our conversations with investors suggest that the fertility theme has been rather overlooked so far," analyst Laia Marin wrote in a note last week, the second part of a two-part look at fertility stocks.

mountain Progyny one-year performance Barclays sees four key catalysts for the group. For one, there are broader fertility policy approaches emerging around the globe, Marin said. Specifically, policies in countries where the population has already peaked — such as Europe, China and Japan — could play a key role in bringing fertility rates back to replacement levels of 2.1 births per woman.

 

コメントありがとうございます。コメントは審査後に公開されます。
このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 12. in JP

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

'Rate cut winners': Barclays names global stocks to buy when interest rates are cutThe investment bank also named two sectors that are likely to behave in a contrarian manner.
ソース: CNBC - 🏆 12. / 72 続きを読む »

Nvidia earnings the next key catalyst for Big Tech: BarclaysNvidia earnings the next key catalyst for Big Tech: Barclays
ソース: Investingcom - 🏆 450. / 53 続きを読む »